Optimism Taking Over in Pharmaceutical Chemicals

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-03-02-2005, Volume 29, Issue 3

After a five-year downturn, cautious optimism is taking hold among API manufacturers.

Related Content:

Bio/Pharma BusinessOutsourcingManufacturingOutsourcing OutlookPharmaceutical Technology-03-02-2005
Increasing mRNA Product Stability with Lyophilization
Bristol Myers Squibb to Access Cellares' Cell Therapy Manufacturing Platform in New $380 Million CAR-T Cell Therapy Deal
INTERPHEX 2024: Implementing Contamination Control Strategies in Cell and Gene Therapy Facilities